Stylianos Michalakis Selected Research

Intraocular Injections

1/2019

Optimized Subretinal Injection Technique for Gene Therapy Approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stylianos Michalakis Research Topics

Disease

11	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2023 - 03/2011
11	Retinal Degeneration 01/2022 - 01/2005
10	Color Vision Defects (Color Blindness) 11/2022 - 10/2013
5	Channelopathies 01/2023 - 01/2009
4	Retinal Dystrophies 08/2023 - 01/2021
4	Blindness (Hysterical Blindness) 03/2021 - 01/2014
3	Retinal Diseases 02/2024 - 06/2017
3	Choroidal Neovascularization 08/2022 - 01/2021
3	Eye Diseases (Eye Disease) 01/2019 - 03/2014
2	Macular Degeneration (Age-Related Maculopathy) 08/2023 - 12/2018
2	Infections 01/2022 - 12/2021
2	Achromatopsia 2 01/2022 - 01/2017
2	Cone Dystrophy 12/2018 - 01/2010
2	Pain (Aches) 01/2017 - 08/2011
2	Cone-Rod Dystrophies 01/2016 - 03/2014
1	Stargardt Disease 10/2023
1	Photophobia (Light Sensitivity) 12/2022
1	Neoplasms (Cancer) 08/2022
1	Achromatopsia 3 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Disease Progression 01/2019
1	Hypoxia (Hypoxemia) 12/2018
1	Ciliopathies 01/2018
1	Retinal Detachment (Retinal Detachments) 07/2015
1	Blister (Bulla) 07/2015
1	Parkinson Disease (Parkinson's Disease) 05/2014
1	congenital stationary Night blindness 03/2014
1	3 X-Linked Cone-Rod Dystrophy 03/2014
1	Hypersensitivity (Allergy) 08/2011
1	Inflammation (Inflammations) 08/2011
1	Ganglion Cysts (Ganglion) 06/2010
1	Gliosis 01/2005

Drug/Important Bio-Agent (IBA)

19	Retinaldehyde (Retinal)IBA 02/2024 - 01/2005
6	Cyclic NucleotidesIBA 09/2022 - 06/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
3	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2023 - 01/2005
3	Rhodopsin (Visual Purple)IBA 01/2020 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2018
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	CationsIBA 01/2021 - 12/2020
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2020 - 12/2010
2	OpsinsIBA 01/2020 - 01/2017
2	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019 - 12/2017
2	Ion Channels (Ion Channel)IBA 12/2018 - 06/2010
1	DepsipeptidesIBA 08/2022
1	vioprolide AIBA 08/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2022
1	CalpainIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Cyclic GMP-Dependent Protein Kinase Type IIIBA 12/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	EnzymesIBA 01/2019
1	NucleosidesIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	pericentrinIBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2017
1	LigandsIBA 06/2017
1	azobenzeneIBA 06/2017
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2017
1	SynucleinsIBA 05/2014
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 03/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2011
1	ZymosanIBA 08/2011
1	Green Fluorescent ProteinsIBA 01/2010

Therapy/Procedure

11	Therapeutics 08/2023 - 10/2013
4	Lasers (Laser) 08/2022 - 01/2010
1	Intravitreal Injections 10/2023
1	Light Coagulation 08/2022
1	Critical Care (Surgical Intensive Care) 12/2021
1	Aftercare (After-Treatment) 01/2020
1	Intraocular Injections 01/2019